FDA approves Moderna's mRNA flu vaccine after initial pushback
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
Watch CBS News
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.
The Trump administration canceled $766 million awarded to drugmaker Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Moderna said on Monday its updated Covid-19 booster generated "significantly higher" neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot.
Federal health officials say thousands of updated booster shots are already being shipped around the country.
